To further identify MSI effects on mutation frequency of altered pathways in CRC, we compared the non-synonymous mutation frequency in the MSH2/MLH1-mutant CRCs (MSI-H) versus the non-MSI-H group lacking identified mutations in MMR genes. The gene discussed is MLH1; the disease is colorectal carcinoma.